| Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160) |
|---|
| 03/30/2004 | US6713650 ABCA-1 elevating compounds |
| 03/30/2004 | US6713606 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 03/30/2004 | US6713514 Such as 2-(benzylamino)-3-(4-(n-(3-phenylpropyl)carbamoyl)-phenyl)propanoic acid |
| 03/30/2004 | CA2305933C (poly)thia-alcynoic compounds and their derivatives, compositions containing them and their uses |
| 03/30/2004 | CA2278687C 5-aroylnaphthalene derivatives |
| 03/30/2004 | CA2123885C Insecticidal phenylhydrazine derivatives |
| 03/25/2004 | WO2004024680A1 Alkyl-s-alkyl hydrazone compounds with insecticide, fungicide, herbicide activities and their preparation |
| 03/25/2004 | WO2004024678A1 Unsaturated sulfur containing-oxime ether compounds with fungicidal activty and their preparation |
| 03/25/2004 | WO2004024139A1 Melanin extinguisher |
| 03/25/2004 | WO2003082260A3 Tuberculosis treatment using pleuromutilin derivatives |
| 03/25/2004 | WO2003070696A3 Substituted aryl ketones |
| 03/25/2004 | US20040059147 Novel process for preparing rac-bicalutamide and its intermediates |
| 03/25/2004 | US20040059110 Such as N,N'-bis(2-hydroxybenzyl)-L-cystine |
| 03/25/2004 | US20040059004 10-aryl-11h-benzo[b]fluorene derivatives and analogs for medicinal use |
| 03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 03/24/2004 | EP1399467A2 Peptide deformylase activated prodrugs |
| 03/24/2004 | EP1399406A2 Novel estrogen receptor ligands and methods i |
| 03/24/2004 | EP1399146A1 Novel compounds and compositions as cathepsin inhibitors |
| 03/24/2004 | EP1214296B1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 03/24/2004 | EP1161232B1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 03/24/2004 | EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/24/2004 | CN1484634A Alkylthio-and aryl (heteroyl) thio substituted p-phenylenediamines their manufacture and their use in rubber |
| 03/23/2004 | US6710205 Benzoic acid derivatives, processes for producing the same and drugs containing the same as the active ingredient |
| 03/23/2004 | US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 03/23/2004 | US6710079 Composition and method for preparing amino acid chelates and complexes free of interfering complex ions |
| 03/23/2004 | US6710073 Drugs that induce long term potentiation (ltp) and enhance cognitive function in mammals |
| 03/23/2004 | US6709645 Synthesis of labeled metabolites |
| 03/18/2004 | WO2004022775A1 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use |
| 03/18/2004 | WO2004022766A1 PROCESS FOR PRODUCING L-α-METHYLCYSTEINE DERIVATIVE |
| 03/18/2004 | WO2004022533A1 Novel vinyl carboxylic acid derivatives and their therapeutical use |
| 03/18/2004 | WO2004022526A1 Cathepsin cysteine protease inhibitors |
| 03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | WO2003099763A8 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors |
| 03/18/2004 | WO2003097576A3 Diamino-functional chalcones |
| 03/18/2004 | WO2003096978A3 Carbon-11 and fluorine-18 labeled radioligands for positron emission tomography (pet) imaging for the brain serotonin transporters |
| 03/18/2004 | WO2003084936A3 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological |
| 03/18/2004 | WO2003018535A3 Novel aminobenzoephenones |
| 03/18/2004 | WO2002103340A3 Method and device for the detection of trace amounts of a substance,using a piezoelectric crystal element |
| 03/18/2004 | US20040054225 Salt formation using calcium compound |
| 03/18/2004 | US20040054190 Imaging prostate cancer |
| 03/18/2004 | US20040054170 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
| 03/18/2004 | US20040054132 Comprises fatty acid-conjugated products with disulfide linkage to proteins/peptides for delivery to cells; increases absorption and prolongs blood and tissue retention |
| 03/18/2004 | US20040053907 Cell adhesion inhibitors |
| 03/18/2004 | US20040053892 Chiral integrin modulators and methods of use thereof |
| 03/18/2004 | US20040053890 Naphthalene derivatives |
| 03/18/2004 | US20040053855 Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives |
| 03/18/2004 | US20040053786 Insecticidal 1,8-naphthalenedicarboxamides |
| 03/18/2004 | US20040052914 Flavouring a foodstuff by incorporating an effective amount of at least one compound of the formula r1-s-r2 in which r1 and r2 represent a specific atom or group |
| 03/18/2004 | CA2499380A1 Novel vinyl carboxylic acid derivatives and their therapeutical use |
| 03/18/2004 | CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | CA2495939A1 Cathepsin cysteine protease inhibitors |
| 03/17/2004 | EP1242364B1 Adamantane derivatives |
| 03/17/2004 | EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion |
| 03/17/2004 | EP0966769B1 Novel electrode materials derived from polyquinoid ionic compounds and their uses in electrochemical generators |
| 03/16/2004 | US6706923 Perfluoroalkyl-substituted amines, acids, amino acids and thioether acids |
| 03/16/2004 | US6706886 Process and novel intermediates for preparing isoxazolin-3-ylacyl benzenes |
| 03/16/2004 | US6706839 Chemical partitioning agents and methods of using same |
| 03/16/2004 | US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/16/2004 | US6706763 Agonistic drug on human peroxisome proliferator-activated receptor (ppar) |
| 03/16/2004 | US6706744 Hypoglycemic agents; antidiabetic agents |
| 03/16/2004 | US6706712 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/11/2004 | WO2004000789A9 Amide linker peroxisome proliferator activated receptor modulators |
| 03/11/2004 | US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease |
| 03/11/2004 | US20040048891 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 03/11/2004 | US20040048856 Monoamine reuptake inhibitors for treatment of CNS disorders |
| 03/11/2004 | US20040047960 For use in foods and/or beverages |
| 03/10/2004 | EP1395615A1 Oxime ester photoinitiators having a combined structure |
| 03/10/2004 | EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 03/10/2004 | EP1395548A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| 03/10/2004 | EP1395530A1 Process for the preparation of amorphous cilastatin sodium |
| 03/10/2004 | EP1395263A1 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| 03/10/2004 | EP1395251A2 Aminediols as agents for the treatment of alzheimer's disease |
| 03/10/2004 | EP1084101B1 New 3-aryl-2-hydroxypropionic acid derivative iii |
| 03/10/2004 | CN1481358A Carboxylic acid amide derivatives and their use in treatment of thromboembolic diseases and tumours |
| 03/10/2004 | CN1481238A Aniline derivatives or salts thereof and cytokine prodn inhibitors contg. same |
| 03/09/2004 | US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder |
| 03/09/2004 | US6703420 Amino-thio-acrylonitriles as MEK inhibitors |
| 03/09/2004 | US6703379 Benzene derivatives and pharmaceutical use thereof |
| 03/09/2004 | US6703042 Salts of L-carnitine and lower alkanoyl L-carnitine |
| 03/09/2004 | US6703031 Cysteine derivatives |
| 03/04/2004 | WO2004018416A1 4-[(alkylsulfanyl)methyl]-1, 2-benzenediol, preparation method thereof and antioxidant containing the same |
| 03/04/2004 | WO2004018415A1 Sulfonamide derivatives, insecticides for agricultural and horticultural use, and usage thereof |
| 03/04/2004 | WO2004018414A2 Antibacterial agents |
| 03/04/2004 | WO2004018410A1 Substituted benzanilide compound and pest control agent |
| 03/04/2004 | WO2003075907A3 Small molecule entry inhibitors |
| 03/04/2004 | WO2002070469A3 Selective pde3b inhibitors and use of the same in therapy |
| 03/04/2004 | US20040044251 Optical communication |
| 03/04/2004 | US20040044249 Novel process for preparing and isolating rac-bicalutamide and its intermediates |
| 03/04/2004 | US20040044227 From 1,3,8-octanetriol |
| 03/04/2004 | US20040044221 Anticancer ganets; drug resistance |
| 03/04/2004 | US20040044081 Hypotensive agents; cardiovascular disorders; anticholesterol agents; antiarrhythmia agents |
| 03/04/2004 | US20040044075 Alpha acyloxyacetamides for kallikrein and urokinase inhibition |
| 03/04/2004 | US20040044072 Substituted hydroxyethylamines |
| 03/04/2004 | US20040044049 Compounds for inhibiting insulin secretion and methods related thereto |
| 03/04/2004 | US20040044048 Anticholesterol agents; cardiovascular disorders |
| 03/04/2004 | US20040044047 Alpha and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 03/04/2004 | US20040044037 Sleep disorders; antidepressants; analgesics; central nervous system disorders |
| 03/04/2004 | US20040043993 Premenstrual tension; anticancer agents; osteoporosis; hormone replacement therapy |
| 03/04/2004 | US20040043459 Racemization and deprotection of special N-protected amino acids in the acylase/racemase system for the total conversion of special N- protected racemic amino acids into optically pure amino acids |
| 03/04/2004 | US20040043426 Using "tethering" where potential ligands are covalently bonded or "tethered" to a target and subsequently identified |